This document analyzes FDA warning letters issued between 2007 and June 2014. It finds that warning letters increased 78% from 2007 to 2013, with pharmaceutical/biotech, medical devices, and food/beverage industries receiving 95.72% of letters. Recent decreases in letters are likely due to reduced FDA funding and inspection freezes. The document predicts letters will rise in 2015 with a proposed FDA budget increase.